NCT01250561View on ClinicalTrials.gov

Reduction of Postherpetic Neuralgia in Herpes Zoster

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Herpes ZosterPost-herpetic Neuralgia
Interventions
DRUG

Gabapentin

gabapentin 300mg/day, titrated up weekly to max tolerated dose or 3600mg/day (whichever is lower), for 4-9 weeks

DRUG

Valacyclovir

valacyclovir 1000mg three-times daily x 7 days

Trial Locations (1)

77030

Center for Clinical Studies, Houston

Sponsors
All Listed Sponsors
lead

Center for Clinical Studies, Texas

OTHER